Noninvasive Evaluation of Liver Fibrosis in a Sample of Putative Inactive HBV Carriers in Rome, Italy
Table 4
HBV-DNA and liver stiffness in the subgroup of 66 patients during the follow-up.
Characteristics
Basal time
12 months
24 months
Change (24 months, basal time)
% change
value
HBV-DNA
561.80 ± 620.01
5200.27 ± 18666.56
5202.76 ± 19597.25
826.1
<0.001
HBV-DNA <2000 UI/ml, n (%)
66 (100%)
51 (77.3%)
56 (84.8%)
−15.2
—
HBV-DNA ≥2000 UI/ml, n (%)
0 (0%)
15 (22.7%)
10 (15.2%)
100.0
Liver stiffness (kPa)
5.80 ± 2.29
5.66 ± 1.43
5.67 ± 1.62
−2.2
Ns
LS < 7.5 kPa, n (%)
50 (75.8%)
54 (81.8%)
54 (81.8%)
8.0
Ns
LS ≥ 7.5 kPa, n (%)
16 (24.2%)
12 (18.2%)
12 (18.2%)
−25.0
Continuous variables are expressed as mean ± standard deviation (SD). A value <0.05 is considered significant (Wilcoxon paired test). For categorical variables, a value <0.05 is considered significant (McNemer’s test).
